The robotic Prostatectomy (dVP) performed with the robotic Surgical System is the fastest growing treatment for prostate cancer today.
The robotic Prostatectomy fully leverages the robotic Surgical System's state-of-the-art technology, including high resolution 3D vision, proprietary EndoWrist® instrumentation, Intuitive Motion and 4th arm. Recent studies indicate that these technological advantages are helping surgeons provide prostate cancer patients with a better surgery than traditional open or conventional laparoscopic approaches can provide.
For most patients, dVP offers substantially less pain and a much shorter recovery than traditional prostatectomy. Other advantages include reduced need for blood transfusions; less scarring and less risk of infection. Moreover, studies suggest that dVP may offer improved cancer control and a lower incidence of impotence and urinary incontinence.